Straumann Holding AG Gross Profit 2012-2021 | SAUHY

Straumann Holding AG annual/quarterly gross profit history and growth rate from 2012 to 2021. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Straumann Holding AG gross profit for the quarter ending December 31, 2021 was $M, a NAN% increase year-over-year.
  • Straumann Holding AG gross profit for the twelve months ending December 31, 2021 was $0M, a NAN% increase year-over-year.
  • Straumann Holding AG annual gross profit for 2021 was $1.685B, a 53.4% increase from 2020.
  • Straumann Holding AG annual gross profit for 2020 was $1.098B, a 9.1% decline from 2019.
  • Straumann Holding AG annual gross profit for 2019 was $1.208B, a 15.95% increase from 2018.
Straumann Holding AG Annual Gross Profit
(Millions of US $)
2021 $1,685
2020 $1,098
2019 $1,208
2018 $1,042
2017 $854
2016 $730
2015 $640
2014 $611
2013 $579
2012 $567
2011 $598
Straumann Holding AG Quarterly Gross Profit
(Millions of US $)
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2018-12-31
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2014-12-31
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.515B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47